Propel Bio Management, LLC / VRDN
Propel Bio Management, LLC’s Viridian Therapeutics Inc Position
Does Propel Bio Management, LLC own Viridian Therapeutics Inc (VRDN)? Yes — 210.2K shares worth $4M (+2.58% of its 13F portfolio) as of Q1 2026, down from 282.5K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
210.2K
% of Portfolio
+2.58%
Quarters Held
3
currently held
Position History VRDN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of VRDN.